Related Experiment Video
Updated: Jul 12, 2025

Anti-Nuclear Antibody Screening Using HEp-2 Cells
Published on: June 23, 2014
Autoantibody Profiling and Anti-Kinesin Reactivity in ANCA-Associated Vasculitis
Federica Mescia1,2,3, Shaghayegh Bayati4, Elisabeth Brouwer5
1Department of Medicine, University of Cambridge, Cambridge CB2 0SP, UK.
Researchers identified novel autoantibodies in ANCA-associated vasculitides (AAV). Anti-KIF4A antibodies were more common in AAV patients, suggesting potential diagnostic and clinical relevance for these autoimmune disease biomarkers.
Area of Science:
- Immunology
- Autoimmunity
- Rheumatology
Background:
- ANCA-associated vasculitides (AAV) are rare autoimmune disorders affecting small blood vessels.
- Improved diagnostic and therapeutic biomarkers are crucial for managing AAV patients.
- Current diagnostic methods for AAV require enhancement through novel autoantibody identification.
Purpose of the Study:
- To profile the autoantibody repertoire in AAV patients.
- To identify novel autoantibodies associated with AAV, its clinical subgroups, or disease activity.
- To assess the specificity of identified autoantibodies against AAV.
Main Methods:
- Screening of 1743 protein fragments from 1561 unique proteins using in-house developed antigen arrays.
- Analysis of 229 serum samples from 137 AAV patients at different disease stages (presentation, remission, relapse).
- Inclusion of control samples from healthy individuals and patients with other autoimmune/inflammatory conditions for specificity assessment.
Main Results:
- Autoreactivity against kinesin family proteins was observed in AAV patients, healthy volunteers, and controls.
- Anti-KIF4A antibodies showed significantly higher prevalence in AAV patients.
- Potential associations between anti-kinesin antibodies and clinical features within the AAV cohort were noted.
Conclusions:
- The study identified anti-KIF4A antibodies as a potentially significant biomarker in AAV.
- Further research is warranted to validate these findings and explore their clinical utility.
- Novel autoantibodies may contribute to a better understanding and management of AAV.
More Related Videos
10:05Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate
Published on: January 17, 2018
09:16Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis
Published on: June 18, 2020